494 related articles for article (PubMed ID: 24789911)
1. ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis.
Condamine T; Kumar V; Ramachandran IR; Youn JI; Celis E; Finnberg N; El-Deiry WS; Winograd R; Vonderheide RH; English NR; Knight SC; Yagita H; McCaffrey JC; Antonia S; Hockstein N; Witt R; Masters G; Bauer T; Gabrilovich DI
J Clin Invest; 2014 Jun; 124(6):2626-39. PubMed ID: 24789911
[TBL] [Abstract][Full Text] [Related]
2. The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2.
Hartwig T; Montinaro A; von Karstedt S; Sevko A; Surinova S; Chakravarthy A; Taraborrelli L; Draber P; Lafont E; Arce Vargas F; El-Bahrawy MA; Quezada SA; Walczak H
Mol Cell; 2017 Feb; 65(4):730-742.e5. PubMed ID: 28212753
[TBL] [Abstract][Full Text] [Related]
3. Elevated endoplasmic reticulum stress reinforced immunosuppression in the tumor microenvironment via myeloid-derived suppressor cells.
Lee BR; Chang SY; Hong EH; Kwon BE; Kim HM; Kim YJ; Lee J; Cho HJ; Cheon JH; Ko HJ
Oncotarget; 2014 Dec; 5(23):12331-45. PubMed ID: 25514597
[TBL] [Abstract][Full Text] [Related]
4. Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody.
Dominguez GA; Condamine T; Mony S; Hashimoto A; Wang F; Liu Q; Forero A; Bendell J; Witt R; Hockstein N; Kumar P; Gabrilovich DI
Clin Cancer Res; 2017 Jun; 23(12):2942-2950. PubMed ID: 27965309
[No Abstract] [Full Text] [Related]
5. Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer.
Nalawade SA; Shafer P; Bajgain P; McKenna MK; Ali A; Kelly L; Joubert J; Gottschalk S; Watanabe N; Leen A; Parihar R; Vera Valdes JF; Hoyos V
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34815355
[TBL] [Abstract][Full Text] [Related]
6. [Thioridazine Sensitizes Apoptotic Effect of TRAIL in Human Lung Cancer PC9 Cells Through ER Stress Mediated Up-regulation of DR5].
Li J; Wang Y; Liu L; Yuan Y; Bao Y
Zhongguo Fei Ai Za Zhi; 2017 Feb; 20(2):80-87. PubMed ID: 28228218
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA induces TRAIL sensitization of human lung cancer cells through selective ER stress induction.
Kim EO; Kang SE; Im CR; Lee JH; Ahn KS; Yang WM; Um JY; Lee SG; Yun M
Int J Oncol; 2016 May; 48(5):2205-12. PubMed ID: 26983803
[TBL] [Abstract][Full Text] [Related]
8. TIMP-2 targets tumor-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesis.
Guedez L; Jensen-Taubman S; Bourboulia D; Kwityn CJ; Wei B; Caterina J; Stetler-Stevenson WG
J Immunother; 2012 Jul; 35(6):502-12. PubMed ID: 22735808
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of A20 expression in tumor microenvironment exerts anti-tumor effect through inducing myeloid-derived suppressor cells apoptosis.
Shao B; Wei X; Luo M; Yu J; Tong A; Ma X; Ye T; Deng H; Sang Y; Liang X; Ma Y; Wu Q; Du W; Du J; Gao X; Wen Y; Fu P; Shi H; Luo S; Wei Y
Sci Rep; 2015 Nov; 5():16437. PubMed ID: 26561336
[TBL] [Abstract][Full Text] [Related]
10. Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Growth in Cholangiocarcinoma.
Loeuillard EJ; Li B; Stumpf HE; Yang J; Willhite JR; Tomlinson JL; Rohakhtar FR; Simon VA; Graham RP; Smoot RL; Dong H; Ilyas SI
Cell Mol Gastroenterol Hepatol; 2024; 17(5):853-876. PubMed ID: 38219900
[TBL] [Abstract][Full Text] [Related]
11. Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer.
Liu CY; Wang YM; Wang CL; Feng PH; Ko HW; Liu YH; Wu YC; Chu Y; Chung FT; Kuo CH; Lee KY; Lin SM; Lin HC; Wang CH; Yu CT; Kuo HP
J Cancer Res Clin Oncol; 2010 Jan; 136(1):35-45. PubMed ID: 19572148
[TBL] [Abstract][Full Text] [Related]
12. Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer.
Albeituni SH; Ding C; Liu M; Hu X; Luo F; Kloecker G; Bousamra M; Zhang HG; Yan J
J Immunol; 2016 Mar; 196(5):2167-80. PubMed ID: 26810222
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of PLCγ2-β-catenin pathway promotes activation and expansion of myeloid-derived suppressor cells in cancer.
Capietto AH; Kim S; Sanford DE; Linehan DC; Hikida M; Kumosaki T; Novack DV; Faccio R
J Exp Med; 2013 Oct; 210(11):2257-71. PubMed ID: 24127488
[TBL] [Abstract][Full Text] [Related]
14. Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice.
Hamilton MJ; Banáth JP; Lam V; Lepard NE; Krystal G; Bennewith KL
Cancer Immunol Immunother; 2012 May; 61(5):643-54. PubMed ID: 22021068
[TBL] [Abstract][Full Text] [Related]
15. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
[TBL] [Abstract][Full Text] [Related]
16. Distinct mechanisms govern populations of myeloid-derived suppressor cells in chronic viral infection and cancer.
Tcyganov EN; Hanabuchi S; Hashimoto A; Campbell D; Kar G; Slidel TW; Cayatte C; Landry A; Pilataxi F; Hayes S; Dougherty B; Hicks KC; Mulgrew K; Tang CA; Hu CA; Guo W; Grivennikov S; Ali MA; Beltra JC; Wherry EJ; Nefedova Y; Gabrilovich DI
J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34228641
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN.
Liu Y; Lai L; Chen Q; Song Y; Xu S; Ma F; Wang X; Wang J; Yu H; Cao X; Wang Q
J Immunol; 2012 Jun; 188(11):5500-10. PubMed ID: 22544933
[TBL] [Abstract][Full Text] [Related]
18. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.
Finke J; Ko J; Rini B; Rayman P; Ireland J; Cohen P
Int Immunopharmacol; 2011 Jul; 11(7):856-61. PubMed ID: 21315783
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL.
Sinha P; Chornoguz O; Clements VK; Artemenko KA; Zubarev RA; Ostrand-Rosenberg S
Blood; 2011 May; 117(20):5381-90. PubMed ID: 21450901
[TBL] [Abstract][Full Text] [Related]
20. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
